2007
DOI: 10.1007/s11606-007-0440-9
|View full text |Cite
|
Sign up to set email alerts
|

Rigorous Development does not Ensure that Guidelines are Acceptable to a Panel of Knowledgeable Providers

Abstract: BACKGROUND: Rigorous guideline development methods are designed to produce recommendations that are relevant to common clinical situations and consistent with evidence and expert understanding, thereby promoting guidelines' acceptability to providers. No studies have examined whether this technical quality consistently leads to acceptability. OBJECTIVE:To examine the clinical acceptability of guidelines having excellent technical quality. DESIGN AND MEASUREMENTS:We selected guidelines covering several musculos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
34
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 56 publications
(34 citation statements)
references
References 31 publications
(38 reference statements)
0
34
0
Order By: Relevance
“…While rigorous development and explicit reporting are necessary, they do not guarantee optimal and acceptable recommendations or better health outcomes for patients and populations. 9,10 The new item assessing the description of strengths and limitations of the body of evidence (i.e., item 9) can be considered as a precursor for clinical validity or appropriateness of the recommendations. The consortium is targeting this area as its next priority for further study in the AGREE A3 initiative.…”
Section: Knowledge Gapsmentioning
confidence: 99%
“…While rigorous development and explicit reporting are necessary, they do not guarantee optimal and acceptable recommendations or better health outcomes for patients and populations. 9,10 The new item assessing the description of strengths and limitations of the body of evidence (i.e., item 9) can be considered as a precursor for clinical validity or appropriateness of the recommendations. The consortium is targeting this area as its next priority for further study in the AGREE A3 initiative.…”
Section: Knowledge Gapsmentioning
confidence: 99%
“…However, they do not evaluate the clinical appropriateness or validity of the recommendations themselves. While rigorous development and explicit reporting are necessary, they do not guarantee optimal and acceptable recommendations or better health outcomes for patients and populations (Nuckols et al, 2008;Watine et al, 2006). The new item assessing the description of strengths and limitations of the body of evidence (i.e., item 9) can be considered as a precursor for clinical validity or appropriateness of the recommendations.…”
mentioning
confidence: 99%
“…Thus, for the purposes of informing practice decisions, these data suggest bottom line clinical advice -new information not captured by the AGREE II -are, not surprisingly, of particular relevance to the clinical community. In response and recognizing that guideline quality as measured with the AGREE II tool does not necessarily predict high clinical validity of the recommendations [9,10], continued research exploring the concept of clinical validity or appropriateness is warranted and is under way (see www.agreetrust.org). In contrast to what emerged with the clinician participants, the policy makers and developers/researchers focused on methodological issues.…”
Section: Discussionmentioning
confidence: 99%